In the present study, we analyzed the influence of three parameters, mutations in WT1 and FLT3 and the translocation of NUP98-NSD1, on the outcome of pediatric patients in the German AML-BFM 2004 and 2012 protocols. The gene discussed is NSD1; the disease is acute myeloid leukemia.